[1]
|
Scott, G., Gillon, T.E., Pels, A., von Dadelszen, P. and Magee, L.A. (2020) Guidelines—Similarities and Dissimilarities: A Systematic Review of International Clinical Practice Guidelines for Pregnancy Hypertension. American Journal of Ob-stetrics and Gynecology, 226, S1222-S1236. https://doi.org/10.1016/j.ajog.2020.08.018
|
[2]
|
Abe, M., Arima, H., Yoshida, Y., et al. (2022) Optimal Blood Pressure Target to Prevent Severe Hypertension in Pregnancy: A Systematic Review and Meta-Analysis. Hypertension Research, 45, 887-899.
https://doi.org/10.1038/s41440-022-00853-z
|
[3]
|
Ontario Health (Quality) (2023) Placental Growth Factor (PlGF)- Based Biomarker Testing to Help Diagnose Pre-Eclampsia in People with Suspected Pre-Eclampsia: A Health Technolo-gy Assessment. Ontario Health Technology Assessment Series, 23, 1-146.
|
[4]
|
Gaccioli, F., Sovio, U., Gong, S., Cook, E., Charnock-Jones, D.S. and Smith, G.C.S. (2023) Increased Placental sFLT1 (Soluble fms-Like Tyrosine Kinase Re-ceptor-1) Drives the Antiangiogenic Profile of Maternal Serum Preceding Preeclampsia but Not Fetal Growth Restriction. Hypertension, 80, 325-334.
https://doi.org/10.1161/HYPERTENSIONAHA.122.19482
|
[5]
|
Arenas, G.A., Docheva, N., Lopes Perdigao, J., Mueller, A., Dada, T. and Rana, S. (2022) Association of Fetal Sex with Angiogenic Factors in Normotensive and Hy-pertensive Pregnancy States. Pregnancy Hypertension, 29, 108-115.
https://doi.org/10.1016/j.preghy.2022.07.003
|
[6]
|
Margioula-Siarkou, G., Margioula-Siarkou, C., Petousis, S., Margaritis, K., Alexandratou, M., Dinas, K., Sotiriadis, A. and Mavromatidis, G. (2021) Soluble Endoglin Concentration in Maternal Blood as a Diagnostic Biomarker of Preeclampsia: A Systematic Review and Meta-Analysis. European Journal of Obstetrics & Gynecology and Reproductive Biology, 258, 366-381. https://doi.org/10.1016/j.ejogrb.2021.01.039
|
[7]
|
Avnon, T., Ascher-Landsberg, J., Yogev, Y. and Many, A. (2022) Clinical Characteristics of Preeclampsia in Twin versus Singleton Pregnancies. The Journal of Maternal-Fetal & Neonatal Medicine, 35, 2273-2277.
https://doi.org/10.1080/14767058.2020.1784872
|
[8]
|
Tingleff, T., Räisänen, S., Vikanes, Å., Sandvik, L., Sugulle, M., Murzakanova, G. and Laine, K. (2023) Different Pathways for Preterm Birth between Singleton and Twin Pregnan-cies: A Population-Based Registry Study of 481,176 Nulliparous Women. BJOG: An International Journal of Obstetrics & Gynaecology, 130, 387-395.
https://doi.org/10.1111/1471-0528.17344
|
[9]
|
任静, 张海燕, 陈慧, 满冬梅. 双胎妊娠绒毛膜性与妊娠结局的关系[J]. 新疆医科大学学报, 2023, 46(3): 338-341.
|
[10]
|
袁文静, 刘惠娜, 于俊杰, 吴莹, 张振宇, 赵先兰. 不同绒毛膜性双胎妊娠结局分析[J]. 中国实用医刊, 2021, 48(6): 8-11.
|
[11]
|
周飞凤, 陈铃, 邓琳, 徐博凌, 陈振斌, 罗金英, 周进福, 林丽华, 颜建英. 不同绒毛膜性自然受孕双胎围产结局分析[J]. 现代妇产科进展, 2020, 29(6): 424-428.
|
[12]
|
武菁菁, 李聪, 马秀玲, 郭月华, 王晓云, 马文革, 翟红卫, 蔡银素. 不同绒毛膜性双胎新生儿不良围产结局的检出率及影响因素[J]. 贵州医科大学学报, 2022, 47(12): 1459-1464.
|
[13]
|
Bartnik, P., Kosin-ska-Kaczynska, K., Kacperczyk, J., et al. (2016) Twin Chorionicity and the Risk of Hypertensive Disorders: Gestational Hypertension and Pre-Eclampsia. Twin Research and Human Genetics, 19, 377-382.
https://doi.org/10.1017/thg.2016.17
|
[14]
|
Campbell, D.M. and Templeton, A. (2004) Maternal Complications of Twin Pregnancy. International Journal of Gynecology & Obstetrics, 84, 71-73. https://doi.org/10.1016/S0020-7292(03)00314-X
|
[15]
|
Shinohara, S., Sunami, R., Kasai, M., Yasuda, G. and Uchida, Y. (2021) Predictive Value of the sFlt-1/PlGF Ratio for Preeclampsia in Twin Pregnancies: A Retrospective Study. Hypertension in Pregnancy, 40, 330-335.
https://doi.org/10.1080/10641955.2021.1987455
|
[16]
|
沈婕, 沈树娜, 邓森灵, 林元, 李炼, 廖薇薇. 基于sFlt-1/PlGF构建预测双胎妊娠子痫前期发生的风险模型[J]. 中国现代医学杂志, 2022, 32(18): 83-89.
|
[17]
|
罗书, 李书明, 黄勇, 等. 子痫前期患者胎盘组织Toll样受体4表达与血清TNF-α及IL-6水平的相关性分析[J]. 临床和实验医学杂志, 2023, 22(13): 1406-1409.
|
[18]
|
Binder, J., Palmrich, P., Pateisky, P., Kalafat, E., Kuessel, L., Zeisler, H., Munkhbaatar, M., Windsperger, K., Thilaganathan, B. and Khalil, A. (2020) The Prognostic Value of Angiogenic Markers in Twin Pregnancies to Predict Delivery Due to Maternal Complications of Preeclampsia. Hypertension, 76, 176-183.
https://doi.org/10.1161/HYPERTENSIONAHA.120.14957
|
[19]
|
杨铧琦, 卢宗杰. 子痫前期患者血清可溶性Endoglin及可溶性Fms样酪氨酸激酶-1水平及其临床意义[J]. 华西医学, 2017, 32(7): 1000-1005.
|
[20]
|
Iannaccone, A., Reisch, B., Mavarani, L., Darkwah Oppong, M., Kimmig, R., Mach, P., Schmidt, B., Köninger, A. and Gellhaus, A. (2022) Soluble Endoglin versus sFlt-1/PlGF Ratio: Detection of Preeclampsia, HELLP Syndrome, and FGR in a High-Risk Cohort. Hypertension in Pregnancy, 41, 159-172. https://doi.org/10.1080/10641955.2022.2066119
|
[21]
|
林燕敏. 子痫前期孕妇血清和胎盘中S100A8/A9表达及临床意义[J]. 中国妇幼保健, 2023, 38(14): 2664-2667.
https://doi.org/10.19829/j.zgfybj.issn.1001-4411.2023.14.038
|
[22]
|
Benkő, Z., Wright, A., Rehal, A., Cimpoca, B., Syngelaki, A., Delgado, J.L., Tsokaki, T., De Alvarado, M., Vojtassakova, D., Malligiannis Ntalianis, K., Chaveeva, P., Del Campo, A., De Ganzo, T., Resta, C., Atanasova, V., Accurti, V., Villalain, C., Aguilera, J., Dojcinovska, D., O’Gorman, N., Plasencia, W., Zingler, E., Dutemeyer, V., Alvar, B., Casanova, M.C. and Nicolaides, K.H. (2021) Pre-diction of Pre-Eclampsia in Twin Pregnancy by Maternal Factors and Biomarkers at 11 - 13 Weeks’ Gestation: Data from EVENTS Trial. Ultrasound in Obstetrics & Gynecology, 57, 257-265. https://doi.org/10.1002/uog.23531
|
[23]
|
Giorgione, V., Melchiorre, K., O’Driscoll, J., Khalil, A., Sharma, R. and Thilaganathan, B. (2022) Maternal Echocardiographic Changes in Twin Pregnancies with and without Pre-Eclampsia. Ultrasound in Obstetrics & Gynecology, 59, 619-626. https://doi.org/10.1002/uog.24852
|
[24]
|
Yagi, K., Kawaguchi, H., Yamamoto, R., Hayashi, S. and Ishii, K. (2022) Incidence of Chest X-Ray Abnormalities Early in the Third Trimester of Twin Pregnancy and Its Relationship with the Subsequent Development of Preeclampsia. Journal of Obstetrics and Gynaecology Research, 48, 87-93. https://doi.org/10.1111/jog.15075
|
[25]
|
叶宁芝, 陈灵林, 蔡婉婉. 重度子痫前期发病主要影响因素及妊娠结局研究[J]. 中国妇幼保健, 2023, 38(15): 2836-2839. https://doi.org/10.19829/j.zgfybj.issn.1001-4411.2023.15.032
|